MARTECH
Prosoma Digital Therapeutics, EVERSANA | September 27, 2022
Prosoma Digital Therapeutics, innovators in reinventing healthcare for oncology patients, has partnered with EVERSANA®, a pioneer of next-generation commercial services to the global life sciences industry, to support the expected launch and commercialisation for Prosoma's digital therapy to support the mental health of cancer patients.
The digital therapy, Living Well, is the company's proprietary application designed to improve the quality of life and reduce stress, anxiety, and depression symptoms related to cancer diagnosis and treatment.EVERSANA's leading experts in launching and commercialising digital therapeutic solutions will help Prosoma navigate regulatory pathways and plan for commercialisation.
"As we looked to navigate the complexity of commercialising our digital solutions in the United States, it became clear we need a partner with the infrastructure and experience to help us move quickly," said Andrzej Jonczyk, Chief Executive Officer, Prosoma U.S.
"As we looked to navigate the complexity of commercialising our digital solutions in the United States, it became clear we need a partner with the infrastructure and experience to help us move quickly," said Andrzej Jonczyk, Chief Executive Officer, Prosoma U.S. "As we spoke with partners across Europe and the world, one name continued to rise to the top and that was EVERSANA. Their integrated platform and deep experience in digital therapeutics make them the perfect partner to help bring our important therapies to patients."
"The future of healthcare continues to evolve as innovative solutions improve the patient journey," said Jim Lang, CEO, EVERSANA. "EVERSANA was built with this in mind. By helping Prosoma, we will provide critical mental health support for cancer patients and caregivers through this novel approach to digital therapy."
EVERSANA and Prosoma Digital Therapeutics will attend and be available to discuss the partnership at the 5th annual DTx East Conference, September 27-29 in Boston, Massachusetts.
ABOUT Prosoma Digital Therapeutics
As a global leader in Digital Therapeutics for oncology, Prosoma provides patients with comprehensive solutions that are fully tailored to their medical conditions. The company created a portfolio of medical software products by combining world-leading expertise in medicine and technology and covering cancer patients' entire behavioural support needs. The company's flagship product, Living Well App, leads the patient from the moment of diagnosis towards regaining control over their wellbeing. It helps patients deal with their emotions and stress, build healthy habits and support them through their recovery process. The Living Well App is already reimbursed by healthcare insurance companies in Germany, and Prosoma is also aiming to have the costs of its products covered by healthcare systems in the US, the UK, and Poland. To learn more about Promosa, visit http://www.prosoma.com or connect through LinkedIn
About EVERSANA™
EVERSANA™ is the leading independent provider of global services to the life sciences industry. The company's integrated solutions are rooted in the patient experience and span all stages of the product life cycle to deliver long-term, sustainable value for patients, prescribers, channel partners and payers. The company serves more than 500 organizations, including innovative start-ups and established pharmaceutical companies, to advance life sciences solutions for a healthier world. To learn more about EVERSANA, visit eversana.com or connect through LinkedIn and Twitter.
Read More
MULTI CHANNEL MARKETING
Sinch, Zapier | September 23, 2022
New integration enables Zapier customers to connect existing business apps and processes to messaging channels with Sinch’s Conversation API
STOCKHOLM, Sweden, and INDIA – September 22, 2022 – Sinch, a global leader in cloud communications and mobile customer engagement, today announced its latest integration with Zapier, an automation platform, to bring the widest range of messaging channels to the 5000+ business apps that Zapier supports through Sinch’s Conversation API (https://zapier.com/apps/sinch/integrations).
Small and medium-sized businesses already use Sinch's MessageMedia, SimpleTexting, and ClickSend products to send SMS messages. The extended integration increases the scope for businesses of all sizes to send messages via messaging channels like WhatsApp, Telegram, or Facebook Messenger.
Sinch’s Conversation API enables businesses to build, enrich and optimize omnichannel interactions with a single integration. With just a few clicks, Zapier’s millions of users — comprising sales and marketing teams, HR departments, and more — can now build simple, automated logic flows between their existing marketing apps and processes and Sinch’s Conversation API to send and receive messages via messaging channels like WhatsApp, SMS, Facebook Messenger or Instagram. This makes it much easier — and faster — for businesses to start using new messaging channels at scale.
Without Sinch and Zapier, integrating new messaging channels and creating automation triggers within a business’ existing processes would require considerable time and effort from a development team, drawing on company resources and slowing down momentum.
Example use cases for the integration include:
Sending WhatsApp messages to a list of opted-in customers stored on Google Drive
Payment confirmation messages sent via SMS when a customer makes a purchase using a brand’s Shopify instance
Creation of a Zendesk ticket when a customer messages a brand via Instagram DMs
With the widest range of channels on the market, and more channels to come, Sinch’s Conversation API positions Zapier users to provide true omnichannel communications to their customers and internal teams, increasing engagement and conversions.
“Messaging channels are immensely important for today’s businesses — they’re where customers are most active, and where they want to connect with their preferred brands and service providers,” said Jon Campbell, Director of Rich Messaging at Sinch. “Our expanded partnership with Zapier provides users with easy access to those channels from a single integration point, reducing headaches for IT departments and laying the groundwork for a true omnichannel conversational messaging strategy.”
Sinch’s MessageMedia integrated with Zapier in 2018, so that users can easily connect with other apps and automate repetitive tasks, such as sending SMS calendar notifications. Users don't need to be a developer and signup is free.
Learn more about the Conversation API integration, and try it for yourself, here: https://zapier.com/apps/sinch/integrations.
For more about Sinch’s MessageMedia integration, see https://integrations.messagemedia.com.
About Sinch
Sinch’s leading cloud communications platform lets businesses reach everyone on the planet, in seconds or less, through mobile messaging, email, voice and video. More than 150,000 businesses, including many of the world’s largest companies and mobile operators, use Sinch’s advanced technology platform to engage with their customers. Sinch has been profitable and fast-growing since its foundation in 2008. It is headquartered in Stockholm, Sweden, and has a local presence in more than 60 countries. Shares are traded at NASDAQ Stockholm: XSTO: SINCH. Visit us at sinch.com.
Read More
CHANNEL PARTNERSHIPS
AscellaHealth | September 26, 2022
AscellaHealth, a global healthcare and specialty pharmacy solutions company, is extremely honored to be named Strategic Channel Partner of the Year at the recent National Association of Specialty Pharmacy (NASP) Annual Meeting & Expo. This award is given to an organization such as a manufacturer, technology provider, GPO, Hub service provider, logistics provider, nonprofit or other that provides a service or solution to facilitate the delivery of high-quality, cost-effective specialty pharmacy care.
Honored to receive this award, Dea Belazi, president and CEO, AscellaHealth says, "This extraordinary recognition by such an esteemed organization as NASP belongs to our talented team of strategic innovators with unparalleled industry experience and expertise. It is extremely gratifying to gain this unique distinction in the specialty pharmacy market and our entire organization is deserving of this hon
Honored to receive this award, Dea Belazi, president and CEO, AscellaHealth says, "This extraordinary recognition by such an esteemed organization as NASP belongs to our talented team of strategic innovators with unparalleled industry experience and expertise. It is extremely gratifying to gain this unique distinction in the specialty pharmacy market and our entire organization is deserving of this honor.”
AscellaHealth is part of The AscellaHealth Family of Companies: including subsidiaries Optime Care dedicated to rare, orphan/ultra-orphan disease patients and Terebellum, a global organization serving pharmaceutical manufacturers.
Belazi continues, "The AscellaHealth Family of Companies provide single-source, end-to-end solutions to tighten the specialty pharmacy value chain. In the highly fragmented current marketplace with multiple vendors handling each stage of the pre-launch, commercialization, distribution and fulfilment processes, manufacturers value our one stop, consultative approach. Most importantly, we are always mindful of putting patients at the center of all our initiatives."
With a focus on optimizing access to expensive specialty and rare disease medications and improving patient outcomes, AscellaHealth provides a full spectrum of cutting-edge programs and services that are valued by all stakeholders, including patients, payers, life sciences manufacturers and providers. AscellaHealth core services include pre-commercialization and market access, comprehensive Hub and patient support, exclusive distribution partnerships and national specialty medication fulfillment, data analytics, supply chain logistics and payer/pharmaceutical financial solutions.
To learn more about AscellaHealth’s unique life sciences solutions, email businessdevelopment@ascellahealth.com
About AscellaHealth LLC
AscellaHealth is a global Healthcare & Specialty Pharmacy solutions organization serving patients, payers, life sciences manufacturers and providers, offering a comprehensive portfolio of customized, tech-enabled specialty pharmaceutical and personalized medical management services. A multiple Inc. 5000 winner, AscellaHealth’s unique, patient-centric approach is built upon proprietary technology processes for innovative programs and services optimizing health outcomes and quality of life for patients with complex chronic conditions or rare diseases that require specialty medications and/or gene and cell therapies. Most recently, AscellaHealth has joined with its subsidiaries, Optime Care and Terebellum to form the AscellaHealth Family of Companies. Visit www.AscellaHealth.com.
Read More